biostudies-literatureUnknown16Dou Y<h4>Background</h4>Cardiovascular disease (CVD) has emerged as the most significant complication and leading cause of death among metabolic-associated fatty liver disease (MAFLD).<h4>Objectives</h4>This study aims to investigate the CVD risk among MAFLD subgroups.<h4>Design</h4>Data of participants from June 2017 to January 2023 in the Physical Examination Center of the Third Hospital of Hebei Medical University were collected. MAFLD were divided into four subgroups: metabolic healthy lean/normal weight MAFLD (MHL), metabolic healthy overweight/obese MAFLD (MHO), metabolic dysfunctional lean/normal weight MAFLD (MDL), and metabolic dysfunctional overweight/obese MAFLD (MDO).<h4>Methods</h4>The risk assessment for atherosclerotic CVD was performed based on the flowchart for primary preventiTherapeutic advances in chronic disease20406223251378867https://www.ebi.ac.uk/biostudies/studies/S-EPMC12497973biostudies-literatureThe relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study.PMC12497973Li JShao JCui JNan YDou YHou MWang QNi WChang CYuan XGu QDong CQiao LfalseThe relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study.<h4>Background</h4>Cardiovascular disease (CVD) has emerged as the most significant complication and leading cause of death among metabolic-associated fatty liver disease (MAFLD).<h4>Objectives</h4>This study aims to investigate the CVD risk among MAFLD subgroups.<h4>Design</h4>Data of participants from June 2017 to January 2023 in the Physical Examination Center of the Third Hospital of Hebei Medical University were collected. MAFLD were divided into four subgroups: metabolic healthy lean/normal weight MAFLD (MHL), metabolic healthy overweight/obese MAFLD (MHO), metabolic dysfunctional lean/normal weight MAFLD (MDL), and metabolic dysfunctional overweight/obese MAFLD (MDO).<h4>Methods</h4>The risk assessment for atherosclerotic CVD was performed based on the flowchart for primary preventi2025-01-01T00:00:00Z20252026-06-04T06:57:54.026Z2026-05-06T03:12:26.033ZS-EPMC124979734105925810.1177/20406223251378867